{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-005022","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2023-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.709050+00:00","generated_at":"2026-06-20T09:39:28.965773+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Health Sciences Acquisitions 2 shareholders approve merger with Orchestra BioMed; closing expected Jan 2023","bullets":["All 9 proposals approved at Jan 24 EGM, including Merger Agreement, Domestication, and Equity Incentive Plan.","Business Combination with Orchestra BioMed to close in January 2023, subject to remaining conditions.","Directors elected for New Orchestra: Eric Rose, Jason Aryeh, Pamela Connealy, Geoffrey Smith, David Hochman, Darren Sherman, Eric Fain.","Vote results: 9.44M for (96.5% of voting) on Business Combination Proposal; quorum of 87.2% achieved."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-005022","json":"https://secwatch.observer/filing/0001213900-23-005022.json","markdown":"https://secwatch.observer/filing/0001213900-23-005022.md","text":"https://secwatch.observer/filing/0001213900-23-005022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023005022/0001213900-23-005022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000121390023005022/ea172160-8k425_health2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T09:39:28.965773+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}